Day One Biopharmaceuticals (DAWN) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Q3 2025 value amounting to -$451.6 million.
- Day One Biopharmaceuticals' Enterprise Value rose 1912.72% to -$451.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$451.6 million, marking a year-over-year increase of 1912.72%. This contributed to the annual value of -$531.7 million for FY2024, which is 4514.11% down from last year.
- Day One Biopharmaceuticals' Enterprise Value amounted to -$451.6 million in Q3 2025, which was up 1912.72% from -$453.1 million recorded in Q2 2025.
- In the past 5 years, Day One Biopharmaceuticals' Enterprise Value registered a high of -$262.7 million during Q1 2022, and its lowest value of -$558.4 million during Q3 2024.
- In the last 4 years, Day One Biopharmaceuticals' Enterprise Value had a median value of -$388.9 million in 2022 and averaged -$403.3 million.
- Within the past 5 years, the most significant YoY rise in Day One Biopharmaceuticals' Enterprise Value was 1912.72% (2025), while the steepest drop was 4877.46% (2025).
- Over the past 4 years, Day One Biopharmaceuticals' Enterprise Value (Quarter) stood at -$342.3 million in 2022, then fell by 7.03% to -$366.3 million in 2023, then tumbled by 45.14% to -$531.7 million in 2024, then grew by 15.07% to -$451.6 million in 2025.
- Its last three reported values are -$451.6 million in Q3 2025, -$453.1 million for Q2 2025, and -$473.0 million during Q1 2025.